you are here: Home News Usfda

Usfda

USFDA to fast-track review of generics tested and made in US, but do Indian drugmakers need to worry?
Stock Market Update: BEL, NTPC Green, Jubilant & More in Focus | March 13
IPA rejects Ohio University study linking higher adverse events to made in India generics
Stocks To Watch: IndusInd, Hindustan Zinc, BEL, NLC India & More | March 11
Stocks On Radar: HFCL, Waaree Energies, IREDA, Orchid Pharma in focus on 20 February
Trump Tariff – How much can it hurt Indian pharma?
USFDA action on Granules does not affect existing products, but new approvals may be impacted
Granules India shares crack 10% after Hyderabad facility gets a rap from US regulator
Cipla: M&A positioning, new US regime are key wild cards
Trump vs Harris: What it means for India and markets
Aurobindo Pharma stock drops 4.5% after USFDA flags 10 observations for arm Apitoria's API unit
Alembic Pharma gets USFDA nod for generic drug used to treat schizophrenia
Suven Pharma hits 52-week high as USFDA closes inspection of unit Casper Pharma
Zydus Lifesciences gets USFDA nod for generic medication to treat Parkinson's disease
Granules India confirms US FDA audit at Gagillapur facility: Report
USFDA pulls up Eugia for manufacturing lapses at its Telangana plant
Aurobindo Pharma stock tumbles after US FDA slaps warning letter to Eugia unit-III
USFDA approves Sun Pharma's drug to treat alopecia areata
Zydus Lifesciences gets USFDA nod for diabetes drug
Zydus Lifesciences stock falls 3% after US FDA classifies Jarod unit as OAI
Alembic Pharmaceuticals gets tentative nod from USFDA for generic Selexipag injection
Indian research company falsified data on Generic Viagra: USFDA
Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solution
Dr Reddy's, Sun Pharma recall drugs in US market: USFDA
Alembic Pharma stock rallies 5% after firm receives USFDA tentative approval for Bosutinib tablets

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Usfda

USFDA to fast-track review of generics tested and made in US, but do Indian drugmakers need to worry?

Stock Market Update: BEL, NTPC Green, Jubilant & More in Focus | March 13

IPA rejects Ohio University study linking higher adverse events to made in India generics

Stocks To Watch: IndusInd, Hindustan Zinc, BEL, NLC India & More | March 11

Stocks On Radar: HFCL, Waaree Energies, IREDA, Orchid Pharma in focus on 20 February

Trump Tariff – How much can it hurt Indian pharma?

USFDA action on Granules does not affect existing products, but new approvals may be impacted

Granules India shares crack 10% after Hyderabad facility gets a rap from US regulator

Cipla: M&A positioning, new US regime are key wild cards

Trump vs Harris: What it means for India and markets

Aurobindo Pharma stock drops 4.5% after USFDA flags 10 observations for arm Apitoria's API unit

Alembic Pharma gets USFDA nod for generic drug used to treat schizophrenia

Suven Pharma hits 52-week high as USFDA closes inspection of unit Casper Pharma

Zydus Lifesciences gets USFDA nod for generic medication to treat Parkinson's disease

Granules India confirms US FDA audit at Gagillapur facility: Report

USFDA pulls up Eugia for manufacturing lapses at its Telangana plant

Aurobindo Pharma stock tumbles after US FDA slaps warning letter to Eugia unit-III

USFDA approves Sun Pharma's drug to treat alopecia areata

Zydus Lifesciences gets USFDA nod for diabetes drug

Zydus Lifesciences stock falls 3% after US FDA classifies Jarod unit as OAI

Alembic Pharmaceuticals gets tentative nod from USFDA for generic Selexipag injection

Indian research company falsified data on Generic Viagra: USFDA

Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solution

Dr Reddy's, Sun Pharma recall drugs in US market: USFDA

Alembic Pharma stock rallies 5% after firm receives USFDA tentative approval for Bosutinib tablets